Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial.
Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1.
Lancet. 2021.
PMID: 34688369
Free PMC article.
Clinical Trial.
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial.
Henderson C, Knapp M, Stirling S, Shepstone L, High J, Ballard C, Bentham P, Burns A, Farina N, Fox C, Fountain J, Francis P, Howard R, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien JT, Price A, Swart AM, Tabet N, Telling T, Thomas AJ, Banerjee S.
Henderson C, et al. Among authors: telling t.
Int Psychogeriatr. 2022 Oct;34(10):905-917. doi: 10.1017/S1041610222000436. Epub 2022 Jul 19.
Int Psychogeriatr. 2022.
PMID: 35852256
Clinical Trial.
Item in Clipboard
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
Banerjee S, Farina N, Henderson C, High J, Stirling S, Shepstone L, Fountain J, Ballard C, Bentham P, Burns A, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Swart AM, Telling T, Tabet N.
Banerjee S, et al. Among authors: telling t.
Health Technol Assess. 2023 Oct;27(23):1-108. doi: 10.3310/VPDT7105.
Health Technol Assess. 2023.
PMID: 37929672
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite